60 Degrees Pharmaceuticals updates investor presentation.
- Filed Form 8-K on 2026-10-06.
- Updated investor presentation for investor meetings.
- Press release announced update to January 2027 hospitalized babesiosis data readout.
SXTPW
60 DEGREES PHARMACEUTICALS, INC. SEC filings
Every EDGAR filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTPW), newest first, with AI summaries and stories.
- Ticker
- SXTPW
- CIK
- 1946563
- Sector
- Biotech and pharma
- Latest filing
- Oct 6
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINEEFFECT60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINEDEL AM60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINES-360 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE NOTABLE10-Q60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINESCHEDULE 13G60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Ownership stake disclosure by Lind Global Fund III LP
Lind Global Fund III LP, filed by
ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE360 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Knight Therapeutics Inc., new insider at SXTPW
Knight Therapeutics Inc., reporting
ROUTINESCHEDULE 13G60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Ownership stake disclosure by Knight Therapeutics Inc.
Knight Therapeutics Inc., filed by
ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINEDEF 14A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE460 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Geoffrey S Dow, insider filing for SXTPW
Geoffrey S Dow, reporting
ROUTINEPRE 14A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE360 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Eric Francois, new insider at SXTPW
Eric Francois, reporting
ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINESCHEDULE 13G/A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Ownership stake disclosure by Knight Therapeutics Inc. (amended)
Knight Therapeutics Inc., filed by
ROUTINESCHEDULE 13G/A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Ownership stake disclosure by CVI Investments, Inc. (amended)
CVI Investments, Inc., filed by
NOTABLE10-Q60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINESCHEDULE 13G/A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)
INTRACOASTAL CAPITAL, LLC, filed by
NOTABLE10-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE424B560 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE424B560 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE424B560 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE8-K60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE ROUTINE460 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Geoffrey S Dow, insider filing for SXTPW
Geoffrey S Dow, reporting
ROUTINE460 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE Geoffrey S Dow, insider filing for SXTPW
Geoffrey S Dow, reporting
ROUTINESCHEDULE 13G/A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE This Schedule 13G/A filing discloses that Ayrton Capital LLC has reduced its beneficial ownership stake in 60 Degrees Pharmaceuticals, Inc. to below 5% of the company's outstanding common stock.
Ayrton Capital LLC, filed by
NOTABLE10-Q60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE 60 Degrees Pharmaceuticals, Inc. (SXTPW) filed its Q3 2025 Form 10-Q, providing investors with a quarterly update on the company's financial performance and operational status.
ROUTINESCHEDULE 13G/A60 DEGREES PHARMACEUTICALS, INC.SXTPWLIVE 2 13G filings
Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
INTRACOASTAL CAPITAL, LLC, filed by